Since 2004, Mitchell Warren has been Executive Director of AVAC, an international non-governmental organization that uses education, policy analysis, advocacy, communications and a network of global collaborations to accelerate the ethical development and global delivery of new and emerging HIV prevention options.
Previously, he served as Senior Director for Vaccine Preparedness at the International AIDS Vaccine Initiative (IAVI) focusing on increasing community understanding and national involvement in AIDS vaccine development; Vice President of International Affairs for The Female Health Company (FHC), manufacturer of the female condom, where he directed efforts to design and implement reproductive health programs and led global advocacy efforts for female-initiated prevention methods; and six years at Population Services International (PSI) designing and implementing social marketing, communications and health promotion activities, including five years running PSI’s project in South Africa.
Warren is president of the TB Alliance Stakeholders Association; member of the President’s Emergency Plan for AIDS Relief (PEPFAR) Scientific Advisory Board (SAB); and board member of the Towards an HIV Cure Initiative of the International AIDS Society (IAS). He is past president of the Global HIV Vaccine Enterprise. In 2013, he helped establish the biennial HIV Research for Prevention conference and is one of the co-chairs for R4P 2021. Warren has degrees in English and History from the University of Wisconsin-Madison and studied health policy at the Johns Hopkins University School of Hygiene and Public Health.
